2021
DOI: 10.1016/s1473-3099(21)00203-6
|View full text |Cite|
|
Sign up to set email alerts
|

Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
184
0
7

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 121 publications
(195 citation statements)
references
References 68 publications
4
184
0
7
Order By: Relevance
“…However, Bruker Autoflex Speed (Bruker Daltonics, Bremen, Germany) contains the mass spectral data of T. dohaense and can reliably identify it [ 10 ]. Sequencing-based platforms targeting the ITS (ITS1-5.8S-ITS2) and LSU regions of fungal DNA have high discriminatory power and can provide accurate identification to the species level [ 8 , 17 , 18 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, Bruker Autoflex Speed (Bruker Daltonics, Bremen, Germany) contains the mass spectral data of T. dohaense and can reliably identify it [ 10 ]. Sequencing-based platforms targeting the ITS (ITS1-5.8S-ITS2) and LSU regions of fungal DNA have high discriminatory power and can provide accurate identification to the species level [ 8 , 17 , 18 ].…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have shown azole-based therapy to be superior to polyene-based therapy for the treatment of invasive trichosporonosis. Azole-polyene combination therapy has no advantage over azole monotherapy [ 12 , 18 , 20 ]. According to the Global guideline for the diagnosis and management of rare yeast infections issued by European Confederation of Medical Mycology (ECMM) in co-operation with International Society for Human and Animal Mycology (ISHAM) and American Society for Microbiology (ASM), treatment of invasive trichosporonosis should consist of either voriconazole or posaconazole for a duration of 4–6 weeks, or until radiological resolution (moderate recommendation) [ 18 ].…”
Section: Discussionmentioning
confidence: 99%
“…Intrinsic resistance of non-Aspergillus moulds to antifungal agents is frequent, and mortality appears to exceed 50% for most of the non-Aspergillus moulds. Of note, new guidelines have been published on mucormycosis, rare moulds and rare yeasts; these include paediatric-specific recommendations (90)(91)(92).…”
Section: Management Of Fungal Infectionsmentioning
confidence: 99%
“…General management principles for IFDs are well established and include the prompt initiation of appropriate antifungal therapy, identification and resistance testing of all invasive isolates, source control, and management of predisposing conditions, as feasible (94). Echinocandins or liposomal amphotericin B (95)(96)(97) are strongly recommended for the (91,92).…”
Section: Management Of Fungal Infectionsmentioning
confidence: 99%
See 1 more Smart Citation